Evotec AI Platform

Accelerating drug discovery and development through integrated AI-driven innovation and advanced technologies.

by Evotec · Drug Discovery AI

Executive Summary

Evotec AI Platform leverages artificial intelligence and machine learning to revolutionize drug discovery and development. It is primarily used by pharmaceutical companies, biotechnology firms, and academic institutions to accelerate target identification, optimize compounds, and enhance preclinical development. The platform's key business value lies in reducing R&D timelines and costs, improving success rates, and enabling data-driven decision-making. Its differentiation stems from integrating AI across a comprehensive suite of R&D services and proprietary platforms, from early discovery to manufacturing.

Use Cases

  • Accelerated target identification and validation in oncology and immunology.
  • Optimization of small molecules and biologics for improved efficacy and safety.
  • Prediction of ADME-Tox properties to de-risk drug candidates.
  • Efficient screening of chemical space to identify active compounds.
  • Translating academic research into viable drug candidates.
  • Developing iPSC-based cell therapies with enhanced safety and efficacy.

Features

Visibility

  • Real-time Data Access: Provides real-time access to integrated data sources through live dashboards for immediate insights.
  • Multi-Omics Data Exploration: Enables management, exploration, and analysis of large molecular biology data sets to uncover hidden connections.
  • Customizable Analytical Tools: Offers customizable tools to empower researchers in interpreting complex data across various disciplines.

Intelligence

  • AI-Driven Target Identification: Uses AI to identify indication-relevant targets and subgroups from multimodal patient data.
  • Compound Design & Optimization: Leverages AI/ML for enhanced compound design, property prediction, and virtual screening, minimizing trial-and-error.
  • Predictive ADME-Tox Modeling: Develops robust ADME-Tox models using AI, based on high-quality experimental data, to assess safety and efficacy.
  • Active Learning & Bayesian Optimization: Employs iterative machine learning cycles and Bayesian optimization to prioritize the most informative compounds for testing, reducing experimental resources.

Support

  • Expert Scientific Collaboration: Partners with clients, offering expert teams to design and implement customized R&D projects.
  • Integrated R&D Programs: Offers fully integrated R&D programs from target identification to preclinical development.
  • Dedicated Data Analytics Services: Provides specialized data analytics services to transform how scientific teams interpret and act on complex data.

Technical Specifications

Architecture
Integrated R&D platform with AI components, leveraging proprietary technologies and a service-oriented approach. PanHunter is offered as SaaS.
Deployment
Cloud/SaaS (for PanHunter) and integrated service delivery model.
Authentication
Not explicitly specified for the general platform, likely enterprise-grade for specific client integrations.
API Available
Yes
MCP Server
No

Infrastructure

  • Internal/Partnered Cloud Infrastructure
  • Global R&D Facilities

AI/ML Stack

  • Machine Learning
  • Bayesian Optimization
  • Generative Models
  • Active Learning
  • In-silico Chemistry
  • AlphaFold (for protein modeling)

Integrations

  • Laboratory Systems
  • Clinical Development

Security & Compliance

Certifications: GDPR

Encryption: Not explicitly specified, but implied for data protection and transfers.

Pricing

Model
Custom enterprise, project-based, milestone and royalty payments
Starting Price
Contact sales
Target Customer
Mid-market to Enterprise (Pharmaceutical, Biotech, Academic)
Contract Type
Custom, long-term strategic partnerships
Free Trial
No (credit card required)

About Evotec

Evotec is a life science company pioneering drug discovery and development by integrating breakthrough science with AI-driven innovation and advanced technologies. They accelerate the journey from concept to cure, offering drug discovery alliance and development services for the biopharma sector. Evotec partners with pharmaceutical and biotechnology companies, academic institutions, and other healthcare stakeholders globally.

Founded: 1993 · Headquarters: Hamburg, Germany · Employees: 1000+ · Public